Imatinib

Generic name: Pronounced as (I mat' in ib)
Brand names
  • Gleevec®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 03/15/2020

Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers and disorders of the blood cells. Imatinib is also used to treat certain types of gastrointestinal stromal tumors (GIST; a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). Imatinib is also used to treat dermatofibrosarcoma protuberans (a tumor that forms under the top layer of skin) when the tumor cannot be removed surgically, has spread to other parts of the body, or has come back after surgery. Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

Imatinib comes as a tablet to take by mouth. It is usually taken with a meal and a large glass of water once or twice a day. Take imatinib at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take imatinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the tablets whole; do not chew or crush them. If you touch or come into direct contact with a crushed tablet, wash the area thoroughly.

If you are unable to swallow imatinib tablets, you may place all of the tablets that you need for one dose into a glass of water or apple juice. Use 50 milliliters (a little less than 2 ounces) of liquid for each 100-mg tablet and 200 milliliters (a little less than 7 ounces) of liquid for each 400-mg tablet. Stir with a spoon until the tablets crumble completely and drink the mixture immediately.

If your doctor has told you to take 800 mg of imatinib, you should take 2 of the 400-mg tablets. Do not take 8 of the 100-mg tablets. The tablet coating contains iron, and you will receive too much iron if you take 8 of the 100-mg tablets.

Your doctor may increase or decrease your dose of imatinib during your treatment. This depends on how well the medication works for you and on the side effects you experience. Talk to your doctor about how you are feeling during your treatment. Continue to take imatinib even if you feel well. Do not stop taking imatinib without talking to your doctor.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking imatinib,

  • tell your doctor and pharmacist if you are allergic to imatinib, any other medications, or any of the ingredients in imatinib tablets. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: acetaminophen (Tylenol), alprazolam (Xanax), amlodipine (Norvasc, in Caduet, Lotrel, Tribenzor, others), atazanavir (Reyataz), atorvastatin (Lipitor, in Caduet), carbamazepine (Carbatrol, Equetro, Tegretol, others), clarithromycin (Biaxin, in Prevpac), cyclosporine (Gengraf, Neoral, Sandimmune), dexamethasone, ergotamine (Ergomar, in Migergot, Cafergot), erythromycin (E.E.S., Eryc, Eryped, others), estazolam, felodipine, fentanyl (Duragesic, Subsys, Fentora, others), fosphenytoin (Cerebyx), indinavir (Crixivan), iron, or iron containing supplements, isradipine, itraconazole (Onmel, Sporanox), ketoconazole, lovastatin (Altoprev), metoprolol (Lopressor, Toprol XL, in Dutoprol), nefazodone, nelfinavir (Viracept), nicardipine (Cardene), nifedipine (Adalat CC, Procardia, others), nimodipine (Nymalize), nisoldipine (Sular), oxcarbazepine (Oxtellar XR, Trileptal), phenobarbital, phenytoin (Dilantin, Phenytek), pimozide (Orap), primidone (Mysoline), quinidine (in Nuedexta), rifabutin (Mycobutin), rifampin (rifadin, rimactane, in Rifamate, Rifater), ritonavir (Norvir, in Kaletra, Technivie, Viekira), saquinavir (Fortovase, Invirase), simvastatin (Zocor, in Vytorin), sirolimus (Rapamune), tacrolimus (Astagraf XL, Envarsus XR, Prograf), telithromycin, triazolam (Halcion), voriconazole (Vfend), and warfarin (Coumadin, Jantoven). Many other medications may also interact with imatinib, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor what herbal products you are taking, especially St. John's wort.

  • tell your doctor if you have or have ever had heart, lung, thyroid, kidney, or liver disease.

  • tell your doctor if you are pregnant or plan to become pregnant. You will have to take a pregnancy test before starting treatment, You should not become pregnant while you are taking imatinib and for 14 days after your final dose. Talk to your doctor about birth control methods that you can use during your treatment. If you become pregnant while taking imatinib, call your doctor. Imatinib may harm the fetus.

  • tell your doctor if you are breastfeeding. You should not breastfeed while you are taking imatinib and for one month after your final dose.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking imatinib.

  • you should know that imatinib may make you dizzy, drowsy, or cause blurred vision. Do not drive a car or operate machinery until you know how this medication affects you.

Do not eat grapefruit or drink grapefruit juice while taking this medication.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Imatinib may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • diarrhea

    • nausea

    • vomiting

    • change in the way things taste

    • mouth sores or swelling inside the mouth

    • loss of appetite

    • weight loss

    • heartburn or indigestion

    • dry mouth

    • headache

    • joint swelling or pain

    • bone pain

    • muscle cramps, spasms, or pain

    • tingling, burning. or prickling feeling on the skin

    • difficulty falling asleep or staying asleep

    • sweating

    • teary eyes

    • pink eye

    • flushing

    • dry skin

    • rash

    • itching

    • nail changes

    • hair loss

  • Some side effects can be serious. If you experience any of these symptoms call your doctor immediately:

    • swelling around the eyes

    • swelling of the hands, feet, ankles, or lower legs

    • sudden weight gain

    • shortness of breath

    • fast, irregular, or pounding heartbeat

    • coughing up pink or bloody mucus

    • increased urination, especially at night

    • chest pain

    • peeling, blistering, or shedding skin

    • yellowing of the skin or eyes

    • blood in the stool

    • unusual bruising or bleeding

    • flu-like symptoms, sore throat, fever, chills, and other signs of infection

    • excessive tiredness or weakness

    • abdominal pain or bloating

  • Imatinib may slow growth in children. Your child's doctor will watch his or her growth carefully. Talk to your child's doctor about the risks of giving imatinib to your child.

  • Imatinib may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • nausea

  • vomiting

  • diarrhea

  • rash

  • swelling

  • extreme tiredness

  • muscle cramps or spasms

  • abdominal pain

  • headache

  • loss of appetite

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to imatinib.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Imatinib.
Repaglinide Repaglinide The metabolism of Repaglinide can be decreased when combined with Imatinib.
Montelukast Montelukast The metabolism of Montelukast can be decreased when combined with Imatinib.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Imatinib can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Leflunomide is combined with Imatinib.
Delavirdine Delavirdine The metabolism of Imatinib can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nevirapine can be decreased when combined with Imatinib.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Imatinib.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Imatinib.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Imatinib.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Imatinib.
Candesartan Candesartan The metabolism of Candesartan can be decreased when combined with Imatinib.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Imatinib.
Clopidogrel Clopidogrel The metabolism of Imatinib can be decreased when combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Imatinib.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Imatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Imatinib.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Guanfacine is combined with Imatinib.
Magnesium Hydroxide Magnesium Hydroxide The absorption of Imatinib can be decreased when combined with Magnesium hydroxide.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Imatinib is combined with Mycophenolic acid.
Paregoric Paregoric The metabolism of Imatinib can be decreased when combined with Morphine.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Imatinib.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Imatinib is combined with Prednisone.
Ranitidine Ranitidine The serum concentration of Ranitidine can be increased when it is combined with Imatinib.
Reserpine Reserpine Reserpine may decrease the excretion rate of Imatinib which could result in a higher serum level.
Sumatriptan Sumatriptan Imatinib may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Imatinib.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Imatinib.
Triamcinolone Triamcinolone The risk or severity of adverse effects can be increased when Imatinib is combined with Triamcinolone.
Zolmitriptan Zolmitriptan The metabolism of Imatinib can be decreased when combined with Zolmitriptan.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Imatinib.
Fluconazole Injection Fluconazole Injection The metabolism of Imatinib can be decreased when combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Imatinib.
Hydromorphone Injection Hydromorphone Injection The metabolism of Hydromorphone can be decreased when combined with Imatinib.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Imatinib.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Imatinib.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Imatinib.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Imatinib.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Methylprednisolone.
Metoclopramide Injection Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Imatinib.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be decreased when combined with Imatinib.
Morphine Injection Morphine Injection The metabolism of Imatinib can be decreased when combined with Morphine.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Imatinib.
Altretamine Altretamine The metabolism of Amphetamine can be decreased when combined with Imatinib.
Cyclosporine Cyclosporine The serum concentration of Cyclosporine can be increased when it is combined with Imatinib.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Imatinib.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Imatinib.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Granisetron is combined with Imatinib.
Torsemide Torsemide The metabolism of Torasemide can be decreased when combined with Imatinib.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Imatinib.
Alosetron Alosetron The metabolism of Imatinib can be decreased when combined with Alosetron.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Imatinib.
Entacapone Entacapone The metabolism of Imatinib can be decreased when combined with Entacapone.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Imatinib is combined with Hydroxychloroquine.
Meloxicam Meloxicam The metabolism of Meloxicam can be decreased when combined with Imatinib.
Oxcarbazepine Oxcarbazepine The metabolism of Imatinib can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Imatinib which could result in a higher serum level.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Imatinib which could result in a higher serum level.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Imatinib is combined with Temozolomide.
Zaleplon Zaleplon The metabolism of Zaleplon can be decreased when combined with Imatinib.
Anakinra Anakinra The metabolism of Imatinib can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Imatinib.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Imatinib.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Imatinib.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Imatinib.
Etanercept Injection Etanercept Injection The metabolism of Imatinib can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Imatinib can be decreased when combined with Modafinil.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Imatinib.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Imatinib.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Imatinib.
Epinephrine Injection Epinephrine Injection The serum concentration of Epinephrine can be increased when it is combined with Imatinib.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Imatinib.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Imatinib.
Escitalopram Escitalopram The serum concentration of Escitalopram can be increased when it is combined with Imatinib.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Imatinib which could result in a higher serum level.
Zonisamide Zonisamide The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Imatinib.
Adalimumab Injection Adalimumab Injection The metabolism of Imatinib can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Imatinib.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Imatinib.
Ezetimibe Ezetimibe Imatinib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Glatiramer.
Teriparatide Injection Teriparatide Injection The therapeutic efficacy of Teriparatide can be decreased when used in combination with Imatinib.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Imatinib.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Imatinib.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Imatinib.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Imatinib.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Imatinib.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Imatinib.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Imatinib.
Aprepitant Aprepitant The metabolism of Aprepitant can be decreased when combined with Imatinib.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Imatinib can be decreased when combined with Interferon beta-1a.
Memantine Memantine The serum concentration of Memantine can be increased when it is combined with Imatinib.
Tegaserod Tegaserod The metabolism of Imatinib can be decreased when combined with Tegaserod.
Tadalafil Tadalafil The metabolism of Tadalafil can be decreased when combined with Imatinib.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Imatinib.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Imatinib.
Progesterone Progesterone The metabolism of Progesterone can be decreased when combined with Imatinib.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Imatinib.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Imatinib.
Infliximab Injection Infliximab Injection The metabolism of Imatinib can be increased when combined with Infliximab.
Oxandrolone Oxandrolone The metabolism of Imatinib can be decreased when combined with Oxandrolone.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Imatinib.
Rifaximin Rifaximin The metabolism of Imatinib can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Imatinib.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Imatinib.
Tinidazole Tinidazole Imatinib may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium Trospium The metabolism of Imatinib can be decreased when combined with Trospium.
Bosentan Bosentan The metabolism of Bosentan can be decreased when combined with Imatinib.
Cinacalcet Cinacalcet The metabolism of Imatinib can be decreased when combined with Cinacalcet.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Imatinib can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Imatinib.
Ganciclovir Ganciclovir The risk or severity of adverse effects can be increased when Ganciclovir is combined with Imatinib.
Palifermin Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Imatinib.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Imatinib.
Voriconazole Voriconazole The metabolism of Voriconazole can be decreased when combined with Imatinib.
Dextroamphetamine Dextroamphetamine The metabolism of Amphetamine can be decreased when combined with Imatinib.
Entecavir Entecavir The metabolism of Imatinib can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Imatinib.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Imatinib can be increased when it is combined with Peginterferon alfa-2b.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Imatinib.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Imatinib.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Imatinib.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Imatinib.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Imatinib.
Deferasirox Deferasirox The serum concentration of Imatinib can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Imatinib can be increased when combined with Phenylephrine.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Imatinib.
Felbamate Felbamate The metabolism of Imatinib can be decreased when combined with Felbamate.
Ranolazine Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Imatinib.
Abatacept Injection Abatacept Injection The metabolism of Imatinib can be increased when combined with Abatacept.
Rasagiline Rasagiline The metabolism of Rasagiline can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The metabolism of Sitagliptin can be decreased when combined with Imatinib.
Varenicline Varenicline The excretion of Varenicline can be decreased when combined with Imatinib.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Imatinib.
Gefitinib Gefitinib The metabolism of Gefitinib can be decreased when combined with Imatinib.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Imatinib.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Imatinib is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Imatinib can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Clofarabine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Imatinib.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Imatinib.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Imatinib.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Imatinib.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Imatinib can be increased when combined with Insulin glulisine.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Imatinib.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Imatinib.
Primaquine Primaquine The metabolism of Imatinib can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Imatinib.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Pemetrexed.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Imatinib.
Lisdexamfetamine Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Imatinib.
Nabilone Nabilone The metabolism of Imatinib can be decreased when combined with Nabilone.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Imatinib.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Imatinib is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Imatinib can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Imatinib.
Dronabinol Dronabinol The metabolism of Dronabinol can be decreased when combined with Imatinib.
Lapatinib Lapatinib The metabolism of Lapatinib can be decreased when combined with Imatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Imatinib.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Imatinib.
Mexiletine Mexiletine The metabolism of Imatinib can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Imatinib can be decreased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Azacitidine.
Ivermectin Ivermectin Imatinib may decrease the excretion rate of Ivermectin which could result in a higher serum level.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Imatinib.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Imatinib.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Imatinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Toremifene is combined with Imatinib.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Imatinib is combined with Bexarotene.
Budesonide Budesonide The risk or severity of adverse effects can be increased when Budesonide is combined with Imatinib.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Imatinib.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Decitabine.
Etravirine Etravirine The metabolism of Etravirine can be decreased when combined with Imatinib.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Imatinib can be decreased when combined with Desvenlafaxine.
Cevimeline Cevimeline The metabolism of Cevimeline can be decreased when combined with Imatinib.
Nebivolol Nebivolol The metabolism of Nebivolol can be decreased when combined with Imatinib.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Imatinib is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Bendamustine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Imatinib.
Certolizumab Injection Certolizumab Injection The metabolism of Imatinib can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Imatinib.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Imatinib.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Imatinib is combined with Estramustine.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Imatinib.
Mitotane Mitotane The metabolism of Imatinib can be increased when combined with Mitotane.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Imatinib.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Imatinib.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Imatinib.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Imatinib.
Eltrombopag Eltrombopag Eltrombopag may decrease the excretion rate of Imatinib which could result in a higher serum level.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Imatinib.
Fesoterodine Fesoterodine The metabolism of Fesoterodine can be decreased when combined with Imatinib.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Imatinib.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Imatinib.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Imatinib.
Prasugrel Prasugrel The metabolism of Prasugrel can be decreased when combined with Imatinib.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Imatinib.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Imatinib.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Imatinib.
Dronedarone Dronedarone Imatinib may increase the QTc-prolonging activities of Dronedarone.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection The metabolism of Palonosetron can be decreased when combined with Imatinib.
Saxagliptin Saxagliptin The metabolism of Saxagliptin can be decreased when combined with Imatinib.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Telavancin is combined with Imatinib.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Imatinib.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Imatinib.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Imatinib is combined with Topotecan.
Golimumab Injection Golimumab Injection The metabolism of Imatinib can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Imatinib.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Imatinib is combined with Asenapine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be decreased when combined with Imatinib.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Imatinib.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be decreased when combined with Imatinib.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Imatinib.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Imatinib.
Dabigatran Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Imatinib.
Tocilizumab Injection Tocilizumab Injection The metabolism of Imatinib can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine The serum concentration of Dalfampridine can be increased when it is combined with Imatinib.
Fingolimod Fingolimod Imatinib may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Imatinib.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Imatinib.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Imatinib.
Vilazodone Vilazodone The metabolism of Imatinib can be decreased when combined with Vilazodone.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Imatinib.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Imatinib.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Imatinib.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Imatinib.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Imatinib.
Linagliptin Linagliptin The serum concentration of Linagliptin can be increased when it is combined with Imatinib.
Rilpivirine Rilpivirine The metabolism of Imatinib can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir Imatinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.
Potassium Iodide Potassium Iodide The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Imatinib.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Imatinib.
Abiraterone Abiraterone The serum concentration of Imatinib can be increased when it is combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Imatinib.
Rivaroxaban Rivaroxaban Imatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ticagrelor Ticagrelor The metabolism of Imatinib can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Imatinib.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Imatinib.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Imatinib.
Clobazam Clobazam The metabolism of Imatinib can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Vemurafenib can be increased when it is combined with Imatinib.
Vismodegib Vismodegib The metabolism of Vismodegib can be decreased when combined with Imatinib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Imatinib.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Imatinib.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Imatinib.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Imatinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Melphalan.
Cabergoline Cabergoline The metabolism of Imatinib can be decreased when combined with Cabergoline.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Imatinib.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding can be increased when Fondaparinux is combined with Imatinib.
Pertuzumab Injection Pertuzumab Injection The risk or severity of cardiotoxicity can be increased when Imatinib is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Carfilzomib.
Iloprost Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Imatinib.
Enzalutamide Enzalutamide The metabolism of Imatinib can be increased when combined with Enzalutamide.
Asparaginase Erwinia Chrysanthemi Injection Asparaginase Erwinia Chrysanthemi Injection The risk or severity of liver damage can be increased when Asparaginase Erwinia chrysanthemi is combined with Imatinib.
Mirabegron Mirabegron The metabolism of Imatinib can be decreased when combined with Mirabegron.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Imatinib.
Bosutinib Bosutinib The metabolism of Imatinib can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Corticotropin.
Teriflunomide Teriflunomide The serum concentration of Imatinib can be decreased when it is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be decreased when combined with Imatinib.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Imatinib.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Imatinib.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Imatinib.
Alogliptin Alogliptin The metabolism of Alogliptin can be decreased when combined with Imatinib.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Imatinib is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Imatinib.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Imatinib.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Imatinib.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Imatinib.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Imatinib.
Ospemifene Ospemifene The metabolism of Ospemifene can be decreased when combined with Imatinib.
Trametinib Trametinib The metabolism of Imatinib can be decreased when combined with Trametinib.
Dolutegravir Dolutegravir Imatinib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Afatinib Afatinib Imatinib may decrease the excretion rate of Afatinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Imatinib.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Imatinib.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Imatinib.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Imatinib.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Imatinib.
Ketorolac Injection Ketorolac Injection The metabolism of Ketorolac can be decreased when combined with Imatinib.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Imatinib can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Imatinib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be decreased when combined with Imatinib.
Apremilast Apremilast The metabolism of Imatinib can be increased when combined with Apremilast.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Imatinib.
Siltuximab Injection Siltuximab Injection The metabolism of Imatinib can be increased when combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Imatinib.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be decreased when combined with Imatinib.
Oritavancin Injection Oritavancin Injection The metabolism of Imatinib can be decreased when combined with Oritavancin.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Imatinib.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Imatinib.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Imatinib.
Edoxaban Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Imatinib.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Imatinib.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Blinatumomab.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Imatinib.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Imatinib.
Riociguat Riociguat Imatinib may decrease the excretion rate of Riociguat which could result in a higher serum level.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Imatinib is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Imatinib.
Secukinumab Injection Secukinumab Injection The metabolism of Imatinib can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Imatinib.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Imatinib.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Imatinib can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Imatinib.
Naloxegol Naloxegol The metabolism of Imatinib can be decreased when combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Imatinib.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Imatinib.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Imatinib which could result in a lower serum level and potentially a reduction in efficacy.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Imatinib is combined with Ivabradine.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Imatinib.
Rolapitant Rolapitant The metabolism of Imatinib can be decreased when combined with Rolapitant.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Imatinib is combined with Prednisolone.
Daclatasvir Daclatasvir Daclatasvir may decrease the excretion rate of Imatinib which could result in a higher serum level.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Imatinib.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Imatinib.
Cariprazine Cariprazine The metabolism of Cariprazine can be decreased when combined with Imatinib.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Imatinib can be increased when combined with Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Imatinib.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Imatinib.
Osimertinib Osimertinib The serum concentration of Imatinib can be decreased when it is combined with Osimertinib.
Alectinib Alectinib The metabolism of Imatinib can be decreased when combined with Alectinib.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Imatinib.
Rifapentine Rifapentine The metabolism of Imatinib can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Lesinurad can be decreased when combined with Imatinib.
Dexamethasone Injection Dexamethasone Injection The metabolism of Imatinib can be increased when combined with Dexamethasone.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Imatinib.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be decreased when combined with Imatinib.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Imatinib.
Cobicistat Cobicistat The metabolism of Cobicistat can be decreased when combined with Imatinib.
Selexipag Selexipag The metabolism of Selexipag can be decreased when combined with Imatinib.
Obeticholic Acid Obeticholic Acid The metabolism of Imatinib can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Imatinib.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Imatinib.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Imatinib is combined with Ribociclib.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Brodalumab.
Parathyroid Hormone Injection Parathyroid Hormone Injection The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Imatinib.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Imatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Imatinib.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Imatinib is combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Valbenazine can be decreased when combined with Imatinib.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Deflazacort is combined with Imatinib.
Safinamide Safinamide Safinamide may decrease the excretion rate of Imatinib which could result in a higher serum level.
Ocrelizumab Injection Ocrelizumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Ocrelizumab.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Imatinib can be increased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Imatinib.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Guselkumab.
Abaloparatide Injection Abaloparatide Injection The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Imatinib.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Imatinib.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Imatinib.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Imatinib.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Imatinib.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Imatinib.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Imatinib.
Acalabrutinib Acalabrutinib The metabolism of Imatinib can be decreased when combined with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Imatinib.
Letermovir Letermovir The metabolism of Imatinib can be decreased when combined with Letermovir.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Imatinib is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Imatinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be decreased when combined with Imatinib.
Apalutamide Apalutamide The metabolism of Imatinib can be increased when combined with Apalutamide.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Imatinib is combined with Penicillamine.
Fostamatinib Fostamatinib Fostamatinib may decrease the excretion rate of Imatinib which could result in a higher serum level.
Avatrombopag Avatrombopag Avatrombopag may decrease the excretion rate of Imatinib which could result in a higher serum level.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Imatinib.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Imatinib.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Imatinib.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Imatinib is combined with Encorafenib.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Imatinib.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Imatinib.
Lusutrombopag Lusutrombopag Imatinib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Imatinib.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Imatinib.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Imatinib.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Imatinib.
Dacomitinib Dacomitinib The metabolism of Imatinib can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Imatinib.
Stiripentol Stiripentol The metabolism of Imatinib can be decreased when combined with Stiripentol.
Talazoparib Talazoparib Imatinib may decrease the excretion rate of Talazoparib which could result in a higher serum level.
Gilteritinib Gilteritinib The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Imatinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Imatinib is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Imatinib.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Imatinib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Imatinib.
Rifamycin Rifamycin The metabolism of Imatinib can be increased when combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Imatinib.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Imatinib can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Imatinib is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Imatinib.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Imatinib.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Imatinib.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Risankizumab.
Alpelisib Alpelisib The serum concentration of Alpelisib can be increased when it is combined with Imatinib.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Imatinib.
Solriamfetol Solriamfetol The serum concentration of Solriamfetol can be increased when it is combined with Imatinib.
Darolutamide Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Imatinib.
Triclabendazole Triclabendazole The metabolism of Triclabendazole can be decreased when combined with Imatinib.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Imatinib is combined with Entrectinib.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Imatinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Imatinib.
Pitolisant Pitolisant The serum concentration of Imatinib can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib Fedratinib may decrease the excretion rate of Imatinib which could result in a higher serum level.
Lefamulin Lefamulin Imatinib may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The metabolism of Imatinib can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Imatinib can be increased when combined with Fosphenytoin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Imatinib.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Imatinib.
Avapritinib Avapritinib The metabolism of Avapritinib can be decreased when combined with Imatinib.
Lasmiditan Lasmiditan The serum concentration of Imatinib can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Imatinib.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Imatinib.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Imatinib.
Ozanimod Ozanimod Imatinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Imatinib.
Rimegepant Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Imatinib.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Imatinib.
Ripretinib Ripretinib Imatinib may decrease the excretion rate of Ripretinib which could result in a higher serum level.
Selpercatinib Selpercatinib The serum concentration of Imatinib can be increased when it is combined with Selpercatinib.
Capmatinib Capmatinib The serum concentration of Imatinib can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Imatinib.
Fenfluramine Fenfluramine The metabolism of Imatinib can be decreased when combined with Fenfluramine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Imatinib.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Imatinib.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Imatinib may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib The metabolism of Imatinib can be decreased when combined with Pralsetinib.
Opicapone Opicapone The metabolism of Imatinib can be decreased when combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Imatinib can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Imatinib.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Imatinib.
Viloxazine Viloxazine The metabolism of Imatinib can be decreased when combined with Viloxazine.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Imatinib.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Imatinib.
Mefenamic Acid Mefenamic Acid The metabolism of Mefenamic acid can be decreased when combined with Imatinib.
Naproxen Naproxen The metabolism of Naproxen can be decreased when combined with Imatinib.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Imatinib.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Imatinib is combined with Hydroxyurea.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Imatinib.
Phenobarbital Phenobarbital The metabolism of Imatinib can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The metabolism of Imatinib can be decreased when combined with Methotrexate.
Primidone Primidone The metabolism of Imatinib can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Imatinib.
Chlorpromazine Chlorpromazine The metabolism of Imatinib can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The metabolism of Diazepam can be decreased when combined with Imatinib.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Imatinib.
Phenoxybenzamine Phenoxybenzamine The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Imatinib.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Imatinib.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Imatinib.
Codeine Codeine The risk or severity of adverse effects can be increased when Codeine is combined with Imatinib.
Tranylcypromine Tranylcypromine The metabolism of Imatinib can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Imatinib can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Imatinib is combined with Procarbazine.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Imatinib.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Imatinib.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Imatinib is combined with Thioridazine.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Imatinib.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Imatinib.
Dapsone Dapsone The metabolism of Dapsone can be decreased when combined with Imatinib.
Sulfadiazine Sulfadiazine The metabolism of Imatinib can be decreased when combined with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Oxycodone can be decreased when combined with Imatinib.
Methadone Methadone The risk or severity of QTc prolongation can be increased when Imatinib is combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Imatinib can be decreased when combined with Oxybutynin.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Imatinib.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Imatinib.
Ibuprofen Ibuprofen The serum concentration of Imatinib can be decreased when it is combined with Ibuprofen.
Orphenadrine Orphenadrine The metabolism of Imatinib can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Imatinib can be decreased when combined with Perphenazine.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Imatinib is combined with Azathioprine.
Fluphenazine Fluphenazine The metabolism of Imatinib can be decreased when combined with Fluphenazine.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Imatinib.
Amoxapine Amoxapine The metabolism of Imatinib can be decreased when combined with Amoxapine.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Imatinib is combined with Sulfasalazine.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be decreased when combined with Imatinib.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Imatinib is combined with Lomustine.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Imatinib.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Imatinib is combined with Cytarabine.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Imatinib is combined with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Imatinib is combined with Dactinomycin.
Carbamazepine Carbamazepine The metabolism of Imatinib can be increased when combined with Carbamazepine.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Imatinib.
Prazosin Prazosin Imatinib may decrease the excretion rate of Prazosin which could result in a higher serum level.
Cimetidine Cimetidine The metabolism of Imatinib can be decreased when combined with Cimetidine.
Warfarin Warfarin Imatinib may increase the anticoagulant activities of Warfarin.
Loperamide Loperamide The risk or severity of QTc prolongation can be increased when Imatinib is combined with Loperamide.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Promethazine is combined with Imatinib.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Imatinib is combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin Imatinib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Imatinib can be increased when combined with Griseofulvin.
Digoxin Digoxin Digoxin may decrease the excretion rate of Imatinib which could result in a higher serum level.
Chloroquine Chloroquine The metabolism of Imatinib can be decreased when combined with Chloroquine.
Quinine Quinine The metabolism of Imatinib can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Imatinib.
Triamterene Triamterene The metabolism of Imatinib can be decreased when combined with Triamterene.
Sulfinpyrazone Sulfinpyrazone The metabolism of Imatinib can be decreased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Imatinib.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Imatinib.
Secobarbital Secobarbital The metabolism of Imatinib can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Imatinib.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Imatinib.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Imatinib.
Probenecid Probenecid The metabolism of Imatinib can be increased when combined with Probenecid.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Imatinib.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Imatinib.
Isoniazid Isoniazid The metabolism of Imatinib can be decreased when combined with Isoniazid.
Rifampin Rifampin The metabolism of Imatinib can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Imatinib.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Imatinib.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Imatinib.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Imatinib.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Imatinib.
Liothyronine Liothyronine The therapeutic efficacy of Liothyronine can be decreased when used in combination with Imatinib.
Methimazole Methimazole The therapeutic efficacy of Methimazole can be decreased when used in combination with Imatinib.
Propylthiouracil Propylthiouracil The therapeutic efficacy of Imatinib can be decreased when used in combination with Propylthiouracil.
Chlorpropamide Chlorpropamide The metabolism of Chlorpropamide can be decreased when combined with Imatinib.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be decreased when combined with Imatinib.
Tolazamide Tolazamide The metabolism of Tolazamide can be decreased when combined with Imatinib.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be decreased when combined with Imatinib.
Dinoprostone Dinoprostone The risk or severity of adverse effects can be increased when Dinoprostone is combined with Imatinib.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Imatinib.
Niacin Niacin The metabolism of Imatinib can be decreased when combined with Niacin.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Imatinib.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Imatinib.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Clemastine is combined with Imatinib.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Imatinib.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Imatinib.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Imatinib.
Methyclothiazide Methyclothiazide The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Imatinib.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Imatinib.
Chlorzoxazone Chlorzoxazone The metabolism of Imatinib can be decreased when combined with Chlorzoxazone.
Folic Acid Folic Acid Imatinib may decrease the excretion rate of Folic acid which could result in a higher serum level.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Imatinib.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Propranolol is combined with Imatinib.
Nortriptyline Nortriptyline The metabolism of Imatinib can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone The metabolism of Imatinib can be decreased when combined with Spironolactone.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Imatinib is combined with Mercaptopurine.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Imatinib.
Allopurinol Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Imatinib.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Imatinib.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Papaverine is combined with Imatinib.
Fluorouracil Injection Fluorouracil Injection The metabolism of Imatinib can be decreased when combined with Fluorouracil.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Imatinib.
Cefaclor Cefaclor Imatinib may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Imatinib.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Imatinib is combined with Dacarbazine.
Calcitonin Salmon Injection Calcitonin Salmon Injection The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Imatinib.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Imatinib.
Ketoconazole Ketoconazole The metabolism of Imatinib can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Imatinib.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Imatinib.
Dipyridamole Dipyridamole Imatinib may decrease the excretion rate of Dipyridamole which could result in a higher serum level.
Vinblastine Vinblastine The metabolism of Imatinib can be decreased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Imatinib.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Imatinib.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Imatinib.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be decreased when combined with Imatinib.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Imatinib.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Imatinib.
Triazolam Triazolam The metabolism of Triazolam can be decreased when combined with Imatinib.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Imatinib.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be decreased when combined with Imatinib.
Diltiazem Diltiazem The risk or severity of QTc prolongation can be increased when Imatinib is combined with Diltiazem.
Nifedipine Nifedipine The risk or severity of QTc prolongation can be increased when Imatinib is combined with Nifedipine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Imatinib.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Imatinib.
Atenolol Atenolol Atenolol may decrease the excretion rate of Imatinib which could result in a higher serum level.
Pindolol Pindolol The metabolism of Pindolol can be decreased when combined with Imatinib.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Imatinib.
Piroxicam Piroxicam The metabolism of Piroxicam can be decreased when combined with Imatinib.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Imatinib.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Imatinib.
Glyburide Glyburide The metabolism of Glyburide can be decreased when combined with Imatinib.
Glipizide Glipizide The metabolism of Glipizide can be decreased when combined with Imatinib.
Indapamide Indapamide The risk or severity of QTc prolongation can be increased when Indapamide is combined with Imatinib.
Nafcillin Injection Nafcillin Injection The metabolism of Imatinib can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Imatinib.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Imatinib.
Labetalol Labetalol The metabolism of Imatinib can be decreased when combined with Labetalol.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Imatinib.
Gemfibrozil Gemfibrozil The metabolism of Imatinib can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Imatinib.
Ketoprofen Ketoprofen The metabolism of Imatinib can be decreased when combined with Ketoprofen.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Imatinib.
Flurbiprofen Flurbiprofen The metabolism of Flurbiprofen can be decreased when combined with Imatinib.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Imatinib.
Buspirone Buspirone The metabolism of Buspirone can be decreased when combined with Imatinib.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Imatinib.
Ciprofloxacin Ciprofloxacin The metabolism of Imatinib can be decreased when combined with Ciprofloxacin.
Diclofenac Diclofenac The metabolism of Diclofenac can be decreased when combined with Imatinib.
Fluoxetine Fluoxetine The serum concentration of Imatinib can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Imatinib.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Imatinib.
Clozapine Clozapine The risk or severity of neutropenia can be increased when Imatinib is combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Imatinib is combined with Idarubicin.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Imatinib.
Fludarabine Injection Fludarabine Injection The therapeutic efficacy of Fludarabine can be decreased when used in combination with Imatinib.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Imatinib.
Clarithromycin Clarithromycin The metabolism of Clarithromycin can be decreased when combined with Imatinib.
Etodolac Etodolac The metabolism of Etodolac can be decreased when combined with Imatinib.
Felodipine Felodipine The metabolism of Imatinib can be decreased when combined with Felodipine.
Nabumetone Nabumetone The metabolism of Imatinib can be decreased when combined with Nabumetone.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Imatinib which could result in a higher serum level.
Simvastatin Simvastatin The serum concentration of Simvastatin can be increased when it is combined with Imatinib.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Imatinib.
Teniposide Injection Teniposide Injection The metabolism of Imatinib can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Imatinib can be decreased when combined with Itraconazole.
Atovaquone Atovaquone The metabolism of Imatinib can be decreased when combined with Atovaquone.
Rifabutin Rifabutin The metabolism of Imatinib can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Imatinib.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Imatinib.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Imatinib.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Imatinib.
Omeprazole Omeprazole The metabolism of Omeprazole can be decreased when combined with Imatinib.
Cisapride Cisapride The metabolism of Imatinib can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be decreased when combined with Imatinib.
Venlafaxine Venlafaxine The metabolism of Imatinib can be decreased when combined with Venlafaxine.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Imatinib.
Fluvoxamine Fluvoxamine The metabolism of Imatinib can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone Imatinib may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Lamotrigine Lamotrigine The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Imatinib.
Losartan Losartan The metabolism of Losartan can be decreased when combined with Imatinib.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Imatinib.
Vinorelbine Injection Vinorelbine Injection The metabolism of Imatinib can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Imatinib is combined with Carboplatin.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Imatinib.
Lansoprazole Lansoprazole Lansoprazole may increase the dermatologic adverse activities of Imatinib.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Imatinib.
Pegaspargase Injection Pegaspargase Injection The risk or severity of liver damage can be increased when Pegaspargase is combined with Imatinib.
Nicardipine Nicardipine The metabolism of Imatinib can be decreased when combined with Nicardipine.
Bupropion Bupropion The metabolism of Imatinib can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Imatinib.
Saquinavir Saquinavir The metabolism of Imatinib can be decreased when combined with Saquinavir.
Metformin Metformin The serum concentration of Metformin can be increased when it is combined with Imatinib.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Imatinib.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be decreased when combined with Imatinib.
Lamivudine Lamivudine Imatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole Riluzole Imatinib may decrease the excretion rate of Riluzole which could result in a higher serum level.
Glimepiride Glimepiride The metabolism of Glimepiride can be decreased when combined with Imatinib.
Anastrozole Anastrozole The risk or severity of cardiotoxicity can be increased when Imatinib is combined with Anastrozole.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Imatinib.
Indinavir Indinavir The metabolism of Indinavir can be decreased when combined with Imatinib.
Ritonavir Ritonavir The serum concentration of Imatinib can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Imatinib.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Imatinib.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Imatinib.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Imatinib.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Imatinib.
Valsartan Valsartan The metabolism of Valsartan can be decreased when combined with Imatinib.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Imatinib can be increased when combined with Insulin lispro.
Pramipexole Pramipexole The serum concentration of Pramipexole can be increased when it is combined with Imatinib.
Donepezil Donepezil The metabolism of Donepezil can be decreased when combined with Imatinib.
Nelfinavir Nelfinavir The metabolism of Nelfinavir can be decreased when combined with Imatinib.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Imatinib.
Loratadine Loratadine The metabolism of Imatinib can be decreased when combined with Loratadine.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Imatinib.
Nilutamide Nilutamide The metabolism of Imatinib can be decreased when combined with Nilutamide.
Flutamide Flutamide The metabolism of Imatinib can be decreased when combined with Flutamide.
Selegiline Selegiline The metabolism of Selegiline can be decreased when combined with Imatinib.
Bicalutamide Bicalutamide The metabolism of Imatinib can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Sertraline can be decreased when combined with Imatinib.
Propafenone Propafenone The metabolism of Imatinib can be decreased when combined with Propafenone.
Raloxifene Raloxifene The metabolism of Imatinib can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Irbesartan can be decreased when combined with Imatinib.
Tamsulosin Tamsulosin The metabolism of Tamsulosin can be decreased when combined with Imatinib.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Imatinib.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Imatinib is combined with Quetiapine.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Imatinib.
Paroxetine Paroxetine The metabolism of Imatinib can be decreased when combined with Paroxetine.
Tolcapone Tolcapone The metabolism of Imatinib can be decreased when combined with Tolcapone.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Citalopram is combined with Imatinib.
Capecitabine Capecitabine The metabolism of Capecitabine can be decreased when combined with Imatinib.
Efavirenz Efavirenz The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Imatinib.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Imatinib.
Pioglitazone Pioglitazone The metabolism of Imatinib can be decreased when combined with Pioglitazone.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Imatinib.
Celecoxib Celecoxib The metabolism of Celecoxib can be decreased when combined with Imatinib.
Rosiglitazone Rosiglitazone The metabolism of Rosiglitazone can be decreased when combined with Imatinib.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Imatinib.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Imatinib is combined with Thalidomide.
Aluminum Hydroxide Aluminum Hydroxide The absorption of Imatinib can be decreased when combined with Aluminum hydroxide.
Nateglinide Nateglinide The metabolism of Nateglinide can be decreased when combined with Imatinib.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Imatinib.
Rabeprazole Rabeprazole The metabolism of Imatinib can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Imatinib.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists